Related Experiment Videos
Tumour angiogenic factor associated with subcutaneous lymphoma
The British Journal of Dermatology
|March 1, 1975
Summary
A subcutaneous lymphoma induced significant blood vessel growth, mimicking vascular tumors. This suggests a diffusable tumor angiogenic factor is crucial for lymphoma survival and may offer therapeutic targets.
Area of Science:
- Oncology
- Vascular Biology
- Tumorigenesis
Background:
- Neoplasm survival relies on developing a vascular network for nutrient supply.
- Cutaneous lymphomas can present with extensive telangiectasia, mimicking vascular neoplasms.
Purpose of the Study:
- To investigate the angiogenic potential of a subcutaneous lymphoma.
- To determine if lymphoma can induce neovascularization independently of direct contact.
Main Methods:
- Subcutaneous lymphoma fragments were implanted onto the hamster cheek pouch membrane.
- Experiments included direct apposition and separation by a microporous filter.
- Control materials were used for comparison.
Main Results:
- Lymphoma fragments induced dramatic neovascularization in both direct apposition and filter-separated models.
- Control materials did not induce significant vascular changes.
- These findings indicate the presence of a diffusable factor promoting blood vessel growth.
Conclusions:
- A diffusable Tumor Angiogenic Factor (TAF) likely plays a vital role in subcutaneous lymphoma survival.
- The induction of neovascularization by lymphoma suggests TAF as a potential therapeutic target.
- Further research into TAF could lead to novel anti-cancer strategies.